An expanding geographic threat.
A full testing menu supported by an algorithmic approach to optimize diagnosis.
Tick-borne diseases (TBDs) occur worldwide, but historically, only certain pockets of the United States posed a risk for infection. However, the geographic range of ticks continues to expand in North America, leading to higher risks of TBD exposure for the public. As a result of increasing exposure and the rising number of potential tick-borne pathogens, it is increasingly important to recognize who to test, when to test, and what test to use for patients who present TBD symptoms.
We offer a full menu of individual tests and panels that aid in the diagnosis of TBDs. In addition, we have developed multiple TBD testing algorithms to help guide and optimize diagnostic testing.
Tick-borne testing algorithms and interpretations.
LYME | Lyme Disease Serology, Serum
- NOTE: Not recommended to perform without initial positive first-tiered equivocal Lyme enzyme immunoassay.
- NOTE: Not recommended to perform with concurrent Lyme disease serology testing (Mayo ID: LYME)
EHRCP | Ehrlichia Antibody Panel, Serum
Rocky Mountain spotted fever
Borrelia miyamotoi disease
Learn more about how to order these tests at your institution.